CoChat

Modified Therapy for Gestational Diabetes Using High-Risk and Low-Risk Fetal Abdominal Circumference Growth to Select Strict Versus Relaxed Maternal Glycemic Targets

Kjos, Siri L., Schaefer-Graf, Ute M. · 2007 · Diabetes Care
Cited by 87

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The traditional treatment goal for ges-tational diabetes mellitus (GDM)has been to achieve “normal ” range values for maternal glucose by diet and or insulin therapy, adapting a strategy suc-cessful in treating pregestational diabetes during pregnancy. Intensive insulin ther-apy to achieve strict euglycemia in GDM pregnancies has improved perinatal mor-bidity; however, it has not eliminated the excess rate of macrosomia compared with the reference populations (1). Increasing evidence suggests that disturbances in the intrauterine metabolic environment pro-duced by GDM appear to increase the risk in offspring for obesity and diabetes. The obesity risk in early childhood in off-spring born to mothers with GDM has been correlated with the birth weight and parental obesity, and those children who were large-for-gestational-age (LGA) at birth had obesity rates close to 40 % com-pared with 25 % in those born with nor-mal weight (2). Studies that have attempted to reduce macrosomia rates by setting very strict glycemic targets during pregnancy have required insulin therapy in two-thirds of the women (3). However, only a minority of offspring of GDM mothers appear to be at risk for fetal over-growth and newborn morbidity, even when GDM is untreated in blinded con-trolled trials (4,5). The Toronto Tri-Hospital Gestational Diabetes Project demonstrated a modest association of newborn morbidity with antenatal mater-nal glucose concentrations, adjusting for other risk factors (6). However, no threshold values that would suggest treat-ment were found. These facts led Buchanan et al. (7) to advocate using fetal ultrasound measure-ments of growth in addition to maternal glycemia to identify which fetuses in utero are at increased and decreased risk for complications. This approach relaxes glycemic targets in women whose fetuses are at low risk for LGA growth and inten-sifies therapy by using stricter glycemic targets for those at high risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc07-s216

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Kjos, S. L., & Schaefer-Graf, U. M.
Venue
Diabetes Care
Published
2007-07-01
Volume
30
Issue
Supplement_2
Pages
S200-S205
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2061470957
Cited by
87
References
7
FWCI
4.20
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.